Randomized, prospective trial of cyclosporine monotherapy versus azathioprine-prednisone from three months after renal transplantation

Transplantation

Volumn 61, Issue 7, 1996, Pages 1038-1046

  Hilbrands, Lukas B ^a   Hoitsma, Andries J ^a   Koene, Robert A P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY CD3; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; AZATHIOPRINE; BLOOD PRESSURE; CHILD; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HEALTH CARE COSTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDNISONE; PROSPECTIVE STUDIES;

EID: 0029971283     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199604150-00009     Document Type: Article

References (42)

1. Walker RG, d'Apice AJF. Non-specific immunosuppression: azathioprine and steroids. In: Morris PJ, ed. Kidney transplantation. Principles and practice. Philadelphia: Saunders, 1994: 202.
2. Manske CL, Kasiske BL. Lipid abnormalities after renal transplantation. In: Keane WF, ed. Contemporary issues in nephrology, vol 24. Lipids and renal disease. New York: Churchill Livingstone, 1991: 37.
3. Mihatsch MJ, Thiel G, Ryffel B. Histopathology of cyclosporine nephrotoxicity. Transplant Proc 1988; 20: 759.
4. Almond PS, Gillingham KJ, Sibley R, et al. Renal transplant function after ten years of cyclosporine. Transplantation 1992; 53: 316.
5. Burke JFJ, Pirsch JD, Ramos EL, et al. Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med 1994; 331: 358.
6. Curtis JJ. Hypertension following kidney transplantation. Am J Kidney Dis 1994; 23: 471.
7. European Multicentre Trial Group. Cyclosporin in cadaveric renal transplantation: one year follow-up of a multicentre trial. Lancet 1983; 2: 986.
8. Calne RY. Cyclosporin in cadaveric renal transplantation: 5-year follow-up of a multicentre trial. Lancet 1987; 2: 506.
9. Johnson RW, Mallick NP, Bakran A, et al. Cadaver renal transplantation without maintenance steroids. Transplant Proc 1989; 21: 1581.
10. Morris PJ, French ME, Dunnill MS, et al. A controlled trial of cyclosporine in renal transplantation with conversion to azathioprine and prednisolone after three months. Transplantation 1983; 36: 273.
11. Hall BM, Tiller DJ, Hardie I, et al. Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine. N Engl J Med 1988; 318: 1499.
12. van Wezel HB, Hilbrands LB, Koene RA, Hoitsma AJ. Conversion from cyclosporine to azathioprine at 3 months after renal transplantation: long-term results. Transplant Proc 1994; 26: 2550.
13. Hollander AAMJ, van Saase JLCM, Kootte AM, et al. Beneficial effects of conversion from Cyclosporin to azathioprine after kidney transplantation. Lancet 1995; 345: 610.
14. Hilbrands LB, Hoitsma AJ, Koene RAP. The effect of immunosuppressive drugs on quality of life after renal transplantation. Transplantation 1995; 59: 1263.
15. Hilbrands LB, Demacker PNM, Hoitsma AJ, Stalenhoef AFH, Koene RAP. The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal transplant recipients. J Am Soc Nephrol 1995; 5: 2073.
16. Pocock SJ. Methods of randomization. In: Clinical trials. A practical approach. Chichester: John Wiley & Sons, 1983: 66.
17. Thorogood J, van Houwelingen JC, Persijn GG, Zantvoort FA, Schreuder GMTH, van-Rood JJ. Prognostic indices to predict survival of first and second renal allografts. Transplantation 1991; 52: 831.
18. Tiggeler RG, Berden JH, Hoitsma AJ, Koene RA. Prevention of acute tubular necrosis in cadaveric kidney transplantation by the combined use of mannitol and moderate hydration. Ann Surg 1985; 201: 246.
19. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31.
20. Thorogood J, van Houwelingen JC, van Rood JJ, Zantvoort FA, Schreuder GM, Persijn GG. Factors contributing to long-term kidney graft survival in Eurotransplant. Transplantation 1992; 54: 152.
21. Opelz G. Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome. Transplantation 1994; 58: 443.
22. Wrenshall LE, Matas AJ, Canafax DM, et al. An increased incidence of late acute rejection episodes in cadaver renal allograft recipients given azathioprine, cyclosporine, and prednisone. Transplantation 1990; 50: 233.
23. Gulanikar AC, MacDonald AS, Sungurtekin U, Belitsky P. The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants. Transplantation 1992; 53: 323.
24. Hoitsma AJ, Tiggeler RG, Wetzels JF, Berden JH, Koene RA. Cyclosporine treatment with conversion after three months is a safe treatment protocol in renal allograft recipients. Transplant Proc 1988; 20: 161.
25. Shen SY, Weir MR, Coughlin TR. Renal allograft biopsy and conversion of cyclosporine to azathioprine. Transplantation 1989; 47: 223.
26. Helling TS, Wood BC, Nelson PW, et al. Elective conversion from cyclosporine to azathioprine in sensitized patients following cadaveric renal transplantation. Am J Kidney Dis 1990; 15: 137.
27. Delmonico FL, Conti D, Auchincloss HJ, et al. Long-term, low-dose cyclosporine treatment of renal allograft recipients. A randomized trial. Transplantation 1990; 49: 899.
28. Sweny P, Lui SF, Scoble JE, Varghese Z, Fernando ON, Moorhead JF. Conversion of stable renal allografts at one year from cyclosporin A to azathioprine: a randomized controlled study. Transplant Int 1990; 3: 19.
29. Spielberger M, Aigner F, Schmid T, Bosmuller C, Konigsrainer A, Margreiter R. Long-term results of cadaveric renal transplantation after conversion from cyclosporine to azathioprine: a controlled randomized trial. Transplant Proc 1988; 20: 169.
30. Hricik DE, O'Toole MA, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 1993; 4: 1300.
31. Kasiske BL, Heim-Duthoy K, Ma JZ. Elective cyclosporine withdrawal after renal transplantation. A meta-analysis. JAMA 1993; 269: 395.
32. Griffin PJ, Da Costa CA, Salaman JR. A controlled trial of steroids in cyclosporine-treated renal transplant recipients. Transplantation 1987; 43: 505.
33. Sinclair NR. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group. Can Med Assoc J 1992; 147: 645.
34. van Acker BAC, Prummel MF, Weber JA, Wiersinga WM, Arisz L. Effect of prednisone on renal function in man. Nephron 1993; 65: 254.
35. Kupin W, Venkat KK, Oh HK, Dienst S. Complete replacement of methylprednisolone by azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients. Transplantation 1988; 45: 53.
36. Showstack J, Katz P, Amend W, Salvatierra O. The association of cyclosporine with the 1-year costs of cadaver-donor kidney transplants. JAMA 1990; 264: 1818.
37. Canafax DM, Gruber SA, Chan GL, et al. The pharmacoeconomics of renal transplantation: increased drug costs with decreased hospitalization costs. Pharmacotherapy 1990; 10: 205.
38. Margreiter R, Bosmuller C, Spielberger M, Schmid T, Konigsrainer A. Cyclosporine (Cy) monotherapy after cadaveric renal transplantation. Transplant Proc 1989; 21: 1591.
39. Versluis DJ, Wenting GJ, Derkx FH, Schalekamp MA, Jeekel J, Weimar W. Who should be converted from cyclosporine to conventional immunosuppression in kidney transplantation, and why. Transplantation 1987; 44: 387.
40. Watson MA, Briggs JD, Junor BJ, et al. Randomised trial of conversion from cyclosporin to azathioprine at one year after renal transplantation. Transplant Proc 1989; 21: 1583.
41. Hricik DE, Whalen CC, Lautman J, et al. Withdrawal of steroids after renal transplantation: clinical predictors of outcome. Transplantation 1992; 53: 41.
42. Heim-Duthoy KL, Chitwood KK, Tortorice KL, Massy ZA, Kasiske BL. Elective cyclosporine withdrawal 1 year after renal transplantation. Am J Kidney Dis 1994; 24: 846.